Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin for diabetic peripheral neuropathy
IRCT20230919059469N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of empagliflozin in diabetic polyneuropathy (DPN) and type 2 diabetes mellitus (T2DM), sponsored by Shahid Sadoughi University of Medical Sciences. Started Nov 2023; status: completed.
02
Drugs
empagliflozin
03
Conditions
diabetic polyneuropathy (DPN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20230919059469N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230919059469N1.